Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             132 results found
no title author magazine year volume issue page(s) type
1 A comparison of clinical and objective measures of freezing of gait in Parkinson's disease Morris, Tiffany R.
2012
18 Supplement 3 p. 572-577
6 p.
article
2 3.203 ADENOVIRUS VECTOR MEDIATED 14-3-3γ GENE TRANSFER PROTECTS DOPAMINERGIC NEURONS IN MODELS OF PARKINSON'S DISEASE Chen, X.
2012
18 Supplement 3 p. S204-
1 p.
article
3 2.212 AFFITOPE® BASED VACCINES: A NOVEL AND SAFE IMMUNOTHERAPEUTIC STRATEGY FOR PARKINSON'S DISEASE Weninger, H.
2012
18 Supplement 3 p. S117-
1 p.
article
4 A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: A new botulinum neurotoxin A Pagan, Fernando L.
2012
18 Supplement 3 p. 441-445
5 p.
article
5 1.007 ANALYSIS OF AGE OF ONSET AND EPIDEMIOLOGICAL FACTORS IN PARKINSONS DISEASE Ravan, A.A.
2012
18 Supplement 3 p. S11-S12
2 p.
article
6 1.038 ANALYSIS OF FACTORS CORRELATED TO CONSTIPATION IN PATIENTS WITH PARKINSON'S DISEASE Tan, H.
2012
18 Supplement 3 p. S19-
1 p.
article
7 3.149 AN EXPERIMENTAL STUDY OF ESTABLISHING PD DYSKINESIA MODEL THROUGH COMPLETE DAMAGE TO SUBSTANTIA NIGRA IN RATS Chen, C.
2012
18 Supplement 3 p. S201-
1 p.
article
8 3.206 A NOVEL NEUROPROTECTIVE THERAPY FOR PARKINSON'S DISEASE USING A VIRAL NON-CODING RNA THAT PROTECTS MITOCHONDRIAL COMPLEX I ACTIVITY Kuan, W.-L.
2012
18 Supplement 3 p. S204-S205
2 p.
article
9 Apolipoprotein E gene (APOE) genotype in Wilson’s disease: Impact on clinical presentation Litwin, T.
2012
18 Supplement 3 p. 367-369
3 p.
article
10 2.150 A POSSIBLE NEW BIOMARKER FOR PARKINSON'S DISEASE: PHARMACOLOGICAL MRI (PHMRI) TO DISCRIMINATE ANIMALS WITH MPTP-VERSUS AGE-RELATED PARKINSONISM IN RHESUS MONKEYS Zhang, Z.
2012
18 Supplement 3 p. S114-
1 p.
article
11 1.110 ASSESSING HYPERSEXUALITY IN PARKINSON'S DISEASE: VALIDATION OF A SCREENING INSTRUMENT de Chazeron, I.
2012
18 Supplement 3 p. S37-
1 p.
article
12 3.040 ASSOCIATION OF INTRON RS12138592 A/G POLYMORPHISM OF UBIQUITIN SPECIFIC PROTEASES (USP24) GENE WITH PARKINSON DISEASE Lin, Z.
2012
18 Supplement 3 p. S179-
1 p.
article
13 1.035 AUTONOMIC SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE: A CLINICAL INVESTIGATION Cao, C.
2012
18 Supplement 3 p. S18-S19
2 p.
article
14 1.1.4 AUTOSOMAL RECESSIVE PARKINSON'S DISEASE Wu, R.M.
2012
18 Supplement 3 p. S1-
1 p.
article
15 Body mass index in Parkinson’s disease: A meta-analysis van der Marck, Marjolein A.
2012
18 Supplement 3 p. 263-267
5 p.
article
16 1.317 CEREBELLAR ATAXIA DUE TO AUTOIMMUNE DISEASE Mercan, M.
2012
18 Supplement 3 p. S76-
1 p.
article
17 3.135 CHANGES OF THE PKA/PP2A/CDK5/DARPP-32 PATHWAY IN 6-OHDA-LESIONED RATS FOLLOWING LONG-TERM TREATMENT WITH L-DOPA Jin, L.
2012
18 Supplement 3 p. S198-
1 p.
article
18 Classifying myoclonus: A riddle, wrapped in a mystery, inside an enigma Carr, Jonathan
2012
18 Supplement 3 p. S174-S176
3 p.
article
19 Clinical correlates of anterior and lateral flexion of the thoracolumbar spine and dropped head in patients with Parkinson’s disease Kashihara, Kenichi
2012
18 Supplement 3 p. 290-293
4 p.
article
20 3.15.4 CLINICAL MANAGEMENT OF PAIN AND FATIGUE IN PD Albanese, A.
2012
18 Supplement 3 p. S168-
1 p.
article
21 Cognitive and olfactory deficits in Machado–Joseph disease: A dopamine transporter study Braga-Neto, Pedro
2012
18 Supplement 3 p. 854-858
5 p.
article
22 3.338 COLLAGEN CELL CARRIER FOR NEURAL CELL CULTURES Zhang, Y.
2012
18 Supplement 3 p. S228-
1 p.
article
23 2.288 COMBINED ZOLPIDEM AND CARBIDOPA/LEVODOPA TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY (PSP): A CASE REPORT WITH VIDEO DOCUMENTATION Chen, S.
2012
18 Supplement 3 p. S137-S138
2 p.
article
24 3.132 COMPARISON OF FOUR GDNF-VARIANTS IN THE 6-OHDA RAT MODEL OF PARKINSON'S DISEASE Piltonen, M.H.
2012
18 Supplement 3 p. S197-
1 p.
article
25 3.067 COMPOUD HETEROZYGOUS ATP7B MUTATIONS LEADING TO HYPOCERULOPLASMINEMIA BUT NOT CLINICAL WILSON'S DISEASE IN AN ADULT PATIENT Teive, H.A.G.
2012
18 Supplement 3 p. S185-S186
2 p.
article
26 1.093 CORRELATION BETWEEN NON MOTOR SYMPTOMS, UNIFIED PARKINSON'S DISEASE RATING SCALE SCORE AND QUALITY OF LIFE Vuletic, V.
2012
18 Supplement 3 p. S33-
1 p.
article
27 2.316 CORRELATION OF RCBF AND SURGICAL OUTCOME IN PARKINSON DISEASE: OBJECTIVE EVALUATION USING STEREOTACTIC EXTRACTION ESTIMATION ANALYSIS IN 123I-IMP SPECT Kajita, Y.
2012
18 Supplement 3 p. S145-
1 p.
article
28 Cortical control of voluntary saccades in Parkinson's disease and pre-emptive perception Javaid, M.A.
2012
18 Supplement 3 p. S100-S103
4 p.
article
29 3.251 CORTICAL INHIBITION AND IMPROVEMENT OF MOTOR PERFORMANCE BY LOW-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OVER M1 IN PARKINSON'S DISEASE Ma, X.
2012
18 Supplement 3 p. S216-
1 p.
article
30 2.372 DEEP BRAIN STIMULATION IN TOURETTE'S SYNDROME: A DESCRIPTION OF 3 PATIENTS WITH EXCELLENT OUTCOME Savica, R.
2012
18 Supplement 3 p. S159-
1 p.
article
31 1.211 DEPRESSION IN THE ELDERLY ASSOCIATED TO VASCULAR PARKINSONISM: A CASE REPORT Soler, C.
2012
18 Supplement 3 p. S49-
1 p.
article
32 2.105 DIAGNOSIS AND MONITORING OF PARKINSON'S DISEASE PATIENTS BASED ON MOTOR SIGNALS Pastor-Sanz, L.
2012
18 Supplement 3 p. S102-
1 p.
article
33 Diffusion tensor imaging: Tract based spatial statistics study in essential tremor Saini, Jitender
2012
18 Supplement 3 p. 477-482
6 p.
article
34 1.124 DISTRIBUTION OF MICROGLIA IN THE POSTNATAL MURINE NIGROSTRIATAL SYSTEM Sharaf, A.
2012
18 Supplement 3 p. S41-
1 p.
article
35 Does robotic gait training improve balance in Parkinson's disease? A randomized controlled trial Picelli, Alessandro
2012
18 Supplement 3 p. 990-993
4 p.
article
36 2.274 DOPAMINE DYSREGULATION SYNDROME WITH SEROTONIN SYNDROME IN PARKINSON'S DISEASE: CASE REPORT Ren, D.D.
2012
18 Supplement 3 p. S134-
1 p.
article
37 3.335 DUAL-RESONANCE GENERATED BY SK-CURRENT AND H-CURRENT AT HYPERPOLARIZED MEMBRANE POTENTIALS AT THETA FREQUENCY IN RAT SNC NEURONS Xue, W.-N.
2012
18 Supplement 3 p. S227-S228
2 p.
article
38 2.229 DYSKINESIA IN PARKINSON'S DISEASE — IMPAIRMENTS OF INHIBITION DURING VOLUNTARY CONTRACTION. A TRANSCRANIAL MAGNETIC STIMULATION (TMS) STUDY Filipović, S.R.
2012
18 Supplement 3 p. S122-
1 p.
article
39 Editorial Board 2012
18 Supplement 3 p. i-
1 p.
article
40 2.368 “EDUTOUR” AND “E-TOUR” A NEW PSYCO-EDUCATIONAL PROGRAMME FOR TOURETTE'S SYNDROME AND THEIR FAMILIES Bayes, A.
2012
18 Supplement 3 p. S158-
1 p.
article
41 Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson's disease Cho, Seung-Yeon
2012
18 Supplement 3 p. 948-952
5 p.
article
42 Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients Fekete, Robert
2012
18 Supplement 3 p. 896-898
3 p.
article
43 3.352 EFFECTS OF GREEN TEA EXTRACT (GTE) ON HALOPERIDOL (HAL) INDUCED NEUROLEPTIC ANXIETY SYNDROME (NAS) AND PARKINSONISM IN RATS Malik, T.
2012
18 Supplement 3 p. S231-S232
2 p.
article
44 1.319 ELECTRONYSTAGMOGRAPHY FINDINGS IN SPINOCEREBELLAR ATAXIA TYPE 3 AND 2 Santos, R.S.
2012
18 Supplement 3 p. S76-S77
2 p.
article
45 3.15.1 EPIDEMIOLOGY AND PHENOMENOLOGY Zhang, Z.
2012
18 Supplement 3 p. S167-S168
2 p.
article
46 Epidemiology, diagnosis and differential diagnosis in Parkinson's disease tremor Baumann, Christian R.
2012
18 Supplement 3 p. S90-S92
3 p.
article
47 Factors related to orthostatic hypotension in Parkinson's disease Perez-Lloret, Santiago
2012
18 Supplement 3 p. 501-505
5 p.
article
48 2.014 FP-CIT DATSCAN DID NOT USEFUL IN DIFFERENTIAL DIAGNOSES OF PARKINSON'S DISEASE SUBGROUPS Ribacoba, R.
2012
18 Supplement 3 p. S94-
1 p.
article
49 3.023 FREQUENCY OF THE MUTATIONS IN THE PARK2, PINK1 AND DJ-1 GENES IN POLISH PATIENTS WITH THE EARLY-ONSET PARKINSON DISEASE Koziorowski, D.
2012
18 Supplement 3 p. S174-S175
2 p.
article
50 2.365 FUNCTIONAL AND CLINICAL MEASURES CORRELATING WITH DRIVING ABILITY IN INDIVIDUALS WITH PARKINSON'S DISEASE Masterson, M.
2012
18 Supplement 3 p. S157-
1 p.
article
51 Genetics of essential tremor Jasinska-Myga, Barbara
2012
18 Supplement 3 p. S138-S139
2 p.
article
52 Genotype–phenotype correlations in THAP1 dystonia: Molecular foundations and description of new cases LeDoux, Mark S.
2012
18 Supplement 3 p. 414-425
12 p.
article
53 3.234 GINSENOSIDE RD PROTECTS NEURONS AGAINST GLUTAMATE-INDUCED EXCITOTOXICITY BY INHIBITING CA2+ INFLUX Zhang, C.
2012
18 Supplement 3 p. S212-
1 p.
article
54 Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3 Siebert, M.
2012
18 Supplement 3 p. 185-190
6 p.
article
55 3.306 GLYCOSAMINOGLYCANS MODULATE ALPHA-SYNUCLEIN AGGREGATION AND APOPTOSIS IN MPP TREATED CELLS Lehri-Boufala, S.
2012
18 Supplement 3 p. S220-
1 p.
article
56 1.122 GSK-3β EXPRESSION IN CEREBROSPINAL FLUID IN PARKINSON'S DISEASE Molina-Arjona, J.A.
2012
18 Supplement 3 p. S40-S41
2 p.
article
57 1.004 HETEROGENEITY OF PARKINSON'S DISEASE Kracunova, K.
2012
18 Supplement 3 p. S11-
1 p.
article
58 3.2.2 HOT TOPICS IN DBS: COGNITIVE AND BEHAVIOURAL SIDE EFFECTS Witt, K.
2012
18 Supplement 3 p. S162-
1 p.
article
59 2.108 IDENTIFICATION AND CHARACTERIZATION OF PARKINSON'S DISEASE IN ASYMPTOMATIC PATIENTS Pasinetti, G.M.
2012
18 Supplement 3 p. S103-
1 p.
article
60 IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study Ahlskog, Matthew C.
2012
18 Supplement 3 p. 748-752
5 p.
article
61 2.319 IMPACT OF DEEP BRAIN STIMULATION ON QUALITY OF LIFE IN PARKINSON'S DISEASE: LONG-TERM FOLLOW-UP Morand, D.
2012
18 Supplement 3 p. S146-
1 p.
article
62 3.223 IMPAIRMENTS OF ERK SIGNAL TRANSDUCTION IN THE BRAIN IN A RAT MODEL OF ANTIDEPRESSANT SENSITIVE CHRONIC DEPRESSION Mondal, A.C.
2012
18 Supplement 3 p. S209-
1 p.
article
63 2.351 IMPROVING FUNCTIONAL OUTCOMES WITH MULTIDISCIPLINARY TEAM ASSESSMENT AND INTERVENTION IN PARKINSON'S DISEASE Padmakumar, C.P.
2012
18 Supplement 3 p. S153-S154
2 p.
article
64 3.320 INSIGHTS INTO THE MECHANISM OF PARADOXICAL KINESIA FROM SUBTHALAMIC NUCLEUS RECORDINGS IN PARKINSON'S DISEASE Anzak, A.
2012
18 Supplement 3 p. S224-
1 p.
article
65 3.303 INTRACELLULAR AND EXTRACELLULAR MECHANISM OF α-SYNUCLEIN METABOLISM Watanabe, Y.
2012
18 Supplement 3 p. S220-
1 p.
article
66 3.081 IS AUTONOMIC INTESTINE DYSFUNCTION IN CHILDHOOD GENETICALLY LINKED TO NEUROLOGICAL DYSFUNCTION? Ghaffari, H.
2012
18 Supplement 3 p. S189-
1 p.
article
67 1.269 IS PERSISTENT TARDIVE DYSTONIA A WORTH PRICE TO PAY FOR? Pavlic, G.
2012
18 Supplement 3 p. S64-
1 p.
article
68 1.286 LONG TERM EFFICACY OF PALLIDAL DEEP BRAIN STIMULATION IN PATIENT WITH DYT 6 DYSTONIA FROM INDIA Sankhla, C. Savant
2012
18 Supplement 3 p. S68-
1 p.
article
69 1.255 LONG-TERM EXPOSURE TO TETRABENAZINE (TBZ) HAS NO ADVERSE OR FAVORABLE IMPACT ON CHOREA AFTER IT IS WITHDRAWN Marshall, F.J.
2012
18 Supplement 3 p. S60-
1 p.
article
70 Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study Elmer, Lawrence W.
2012
18 Supplement 3 p. 488-493
6 p.
article
71 LRRK2 I2020T mutation is associated with tau pathology Ujiie, Sachiko
2012
18 Supplement 3 p. 819-823
5 p.
article
72 1.303 MEASURING ARM SWING DURING GAIT IN PATIENTS WITH PARKINSON'S DISEASE USING WEARABLE SENSORS – A FEASIBILITY STUDY Mirelman, A.
2012
18 Supplement 3 p. S72-S73
2 p.
article
73 2.302 MICRORECORDING OPTIMIZES FINAL ELECTRODE PLACEMENT FOR SUBTHALAMIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE Mandat, T.
2012
18 Supplement 3 p. S141-
1 p.
article
74 Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease Boeve, Bradley F.
2012
18 Supplement 3 p. S41-S44
4 p.
article
75 1.2.3 MISFOLDED α-SYNUCLEIN AND NEUROINFLAMMATION AS THERAPEUTIC TARGETS FOR PARKINSON'S DISEASE Maguire-Zeiss, K.A.
2012
18 Supplement 3 p. S2-
1 p.
article
76 1.14.1 MOOD DISORDERS Tan, L.
2012
18 Supplement 3 p. S7-
1 p.
article
77 3.057 MOVEMENT DISORDERS ARE PREVALENT IN PATIENTS WITH FAMILIAL CREUTZFELDT-JAKOB DISEASE (F-CJD) CARRYING THE E200K MUTATION Cohen, O.
2012
18 Supplement 3 p. S183-
1 p.
article
78 2.008 MR IMAGING BIOMARKERS FOR DIFFERENTIATION OF PARKINSON DISEASE FROM HEALTHY CONTROLS USING DIFFUSION TENSOR IMAGING ON 3 TESLA MRI Kumari, R.
2012
18 Supplement 3 p. S92-S93
2 p.
article
79 3.026 MUTATIONAL ANALYSIS OF PARK2, SNCA AND LRRK2 IN PARKINSON'S DISEASE PATIENTS OF SOUTH INDIA Vishwanathan, P.
2012
18 Supplement 3 p. S175-
1 p.
article
80 2.133 NEURON-SPECIFIC PROTEIN ENOLASE AS DIAGNOSTIC MARKER OF PARKINSON DISEASE Usmanova, D.
2012
18 Supplement 3 p. S109-S110
2 p.
article
81 2.031 NEUROPHYSIOLOGICAL CORRELATES OF COGNITIVE DECLINE IN PARKINSON'S DISEASE: A LONGITUDINAL MAGNETOENCEPHALOGRAPHIC STUDY Dubbelink, K.T.E. Olde
2012
18 Supplement 3 p. S99-
1 p.
article
82 Neurorestoration by physical exercise: Moving forward Zigmond, Michael J.
2012
18 Supplement 3 p. S147-S150
4 p.
article
83 New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism Barbano, Richard L.
2012
18 Supplement 3 p. 737-741
5 p.
article
84 2.5.4 NON-MOTOR SYMPTOMS OF PD: CLINICAL RECOGNITION AND TREATMENT OF AUTONOMIC NERVE DYSFUNCTION Wang, M.-W.
2012
18 Supplement 3 p. S83-S84
2 p.
article
85 2.243 OPICAPONE: CHARACTERIZATION OF A NOVEL PERIPHERAL LONG-ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR Bonifacio, M.J.
2012
18 Supplement 3 p. S125-
1 p.
article
86 3.106 PARAQUAT NEUROTOXICITY IS MEDIATED BY THE DOPAMINE TRANSPORTER AND ORGANIC CATION TRANSPORTER-3 Rappold, P.
2012
18 Supplement 3 p. S190-S191
2 p.
article
87 Parkinsonism and dropped head: Dystonia, myopathy or both? Savica, Rodolfo
2012
18 Supplement 3 p. 30-34
5 p.
article
88 1.013 PARKINSONISM IN GHANA: OBJECTIVES, CLINICAL AND GENETICS FINDINGS FROM A 3-YEAR INTERNATIONAL PROJECT Cilia, R.
2012
18 Supplement 3 p. S13-
1 p.
article
89 2.13.1 PATHOLOGY IN ESSENTIAL TREMOR Shill, H.
2012
18 Supplement 3 p. S86-
1 p.
article
90 Patient-centeredness in PD care: Development and validation of a patient experience questionnaire van der Eijk, Martijn
2012
18 Supplement 3 p. 1011-1016
6 p.
article
91 Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease van de Berg, Wilma D.J.
2012
18 Supplement 3 p. S28-S30
3 p.
article
92 3.102 PERINATAL LPS EXPOSURE INCREASES THE RISK FOR DOPAMINERGIC DISORDERS IN ADULT LIFE Cai, Z.
2012
18 Supplement 3 p. S190-
1 p.
article
93 2.2.1 PET STUDIES IN PARKINSON'S DISEASE MOTOR AND COGNITIVE DYSFUNCTION Pavese, N.
2012
18 Supplement 3 p. S82-
1 p.
article
94 2.1.2 PHENOTYPES OF PARKINSONIAN TREMOR Deuschl, G.
2012
18 Supplement 3 p. S81-
1 p.
article
95 1.021 POSTURAL ABNORMALITY IN PARKINSON'S DISEASE IS A RISK FACTOR FOR LEG DEEP VEIN THROMBOSIS Yamane, K.
2012
18 Supplement 3 p. S15-
1 p.
article
96 Pre-death grief in Parkinson's caregivers: A pilot survey-based study Carter, J.H.
2012
18 Supplement 3 p. S15-S18
4 p.
article
97 Presymptomatic Parkinson's disease: The Arizona experience Caviness, John N.
2012
18 Supplement 3 p. S203-S206
4 p.
article
98 3.118 PRIMATE AND RODENT MODELS OF PARKINSON'S DISEASE BASED ON VIRAL VECTOR MEDIATED OVEREXPRESSION OF ALPHA SYNUCLEIN Koprich, J.B.
2012
18 Supplement 3 p. S193-
1 p.
article
99 1.300 PSYCHOGENIC MOVEMENT DISORDER DURING THE FIRST GREAT WAR Geny, C.
2012
18 Supplement 3 p. S72-
1 p.
article
100 1.228 RECORDING PATHOLOGICAL TREMOR WITH A SMARTPHONE Carignan, B.
2012
18 Supplement 3 p. S53-
1 p.
article
101 2.017 RELATIONSHIP BETWEEN VISUAL HALLUCINATIONS AND CEREBRAL BLOOD FLOW ABNORMALITY IN PARKINSON'S DISEASE Okada, K.
2012
18 Supplement 3 p. S95-
1 p.
article
102 Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson’s disease Leonardi, Matilde
2012
18 Supplement 3 p. 35-39
5 p.
article
103 Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's disease Elbers, Roy G.
2012
18 Supplement 3 p. 532-536
5 p.
article
104 2.333 REMISSION OF L-DOPA RESPONSIVE PAIN IN PARKINSON'S DISEASE AFTER SUBTHALAMIC DEEP BRAIN STIMULATION Sueruecue, O.
2012
18 Supplement 3 p. S149-
1 p.
article
105 Restless legs syndrome in Chinese elderly people of an urban suburb in Shanghai: A community-based survey Ma, Jian-Fang
2012
18 Supplement 3 p. 294-298
5 p.
article
106 Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders Vallelunga, Annamaria
2012
18 Supplement 3 p. 397-399
3 p.
article
107 1.069 SELF ASSESSMENT SCALE FOR DOPAMINE DEPENDENT BEHAVIOURS IN PARKINSON'S DISEASE Schmitt, E.
2012
18 Supplement 3 p. S27-
1 p.
article
108 1.141 SEROTONERGIC DRUGS IN THE TREATMENT OF PARKINSONISM: STUDIES ON RAT MODEL Haleem, D.J.
2012
18 Supplement 3 p. S45-S46
2 p.
article
109 1.052 SLEEP DISORDERS IN DIFFERENT CLINICAL SUBGROUPS OF PARKINSON'S DISEASE Fan, L.
2012
18 Supplement 3 p. S22-S23
2 p.
article
110 SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population Trotta, Luca
2012
18 Supplement 3 p. 257-262
6 p.
article
111 SNP rs356219 of the α-synuclein (SNCA) gene is associated with Parkinson’s disease in a Chinese Han population Pan, Fenghua
2012
18 Supplement 3 p. 632-634
3 p.
article
112 3.009 SOME GENETIC ASPECTS OF PARKINSON'S DISEASE IDENTIFIED IN THE ARAL SEA REGION, THE REPUBLIC OF UZBEKISTAN Izyumov, D.
2012
18 Supplement 3 p. S171-
1 p.
article
113 3.209 S-SULFHYDRATION OF β-TUBULIN BY HYDROGEN SULFIDE INCREASES MICROTUBULE STABILITY AND PROTECTS CELLS AGAINST ROTENONE-INDUCED CELL INJURY Xie, L.
2012
18 Supplement 3 p. S205-
1 p.
article
114 1.127 THE DYNAMIC OF FUNCTIONAL INTERHEMISPHERIC ASYMMETRY IN PATIENTS WITH PARKINSON'S DISEASE Bykanova, M.
2012
18 Supplement 3 p. S42-
1 p.
article
115 3.236 THE EFFECTS OF (−)-EPIGALLOCATECHIN-3-GALLATE IN PARKINSONIAN RATS WITH PARTIAL UNILATERAL 6-HYDROXYDOPAMINE-LESION Kääriäinen, T.M.
2012
18 Supplement 3 p. S212-
1 p.
article
116 The effects of gait impairment with and without freezing of gait in Parkinson’s disease Josiah, Anne F.
2012
18 Supplement 3 p. 239-242
4 p.
article
117 2.260 THE EFFICACY AND SAFETY OF 24 HOUR ROTIGOTINE TRANSDERMAL PATCH IN THE TREATMENT OF EARLY PARKINSON'S DISEASE: A META-ANALYSIS Ramiro, G.M.
2012
18 Supplement 3 p. S130-
1 p.
article
118 2.246 THE EFFICACY AND SAFETY OF TOLCAPONE IN PATIENTS WITH PARKINSON'S DISEASE Zhang, C.
2012
18 Supplement 3 p. S126-
1 p.
article
119 3.9.1 THE NEURODEGENERATIONS: GENOMICS FROM A PERPLEXED CLINICIAN Stern, G.
2012
18 Supplement 3 p. S165-
1 p.
article
120 1.096 THE RELATIONSHIP BETWEEN JOINT CONFIGURATION AND HAPTIC SENSITIVITY IN PATIENTS WITH PARKINSON'S DISEASE Chu, P.-Y.
2012
18 Supplement 3 p. S34-
1 p.
article
121 2.123 THE SPECIFICITY OF POWER-LAW EXPONENT TO EVALUATE THE SEVERITY OF MOVEMENT DISORDERS FOR PARKINSON'S DISEASE Wu, C.
2012
18 Supplement 3 p. S107-
1 p.
article
122 2.147 THE STUDY OF ANORECTAL MANOMETRY FOR MULTIPLE SYSTEM ATROPHY AND PARKINSON DISEASE Liu, X.
2012
18 Supplement 3 p. S113-
1 p.
article
123 2.19.4 THE VALUE OF CARE IN PARKINSON'S DISEASE Bloem, B.
2012
18 Supplement 3 p. S91-
1 p.
article
124 1.214 THROMBOEMBOLIC RISK AND THERAPY IN A PATIENT WITH PARKINSON'S DISEASE Thomas, L.
2012
18 Supplement 3 p. S50-
1 p.
article
125 2.285 TRANSDERMAL ROTIGOTINE CAUSES IMPULSE CONTROL DISORDERS IN PATIENTS WITH RESTLESS LEGS SYNDROME Schreglmann, S.R.
2012
18 Supplement 3 p. S136-S137
2 p.
article
126 1.272 TRIGEMINAL SOMATOSENSORY EVOKED POTENTIALS RESEARCH IN PATIENTS WITH MEIGE SYNDROME Kaiyue, W.
2012
18 Supplement 3 p. S65-
1 p.
article
127 Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson’s disease Amara, Amy W.
2012
18 Supplement 3 p. 63-68
6 p.
article
128 Upcoming treatments in Parkinson's disease, including gene therapy Rodnitzky, Robert L
2012
18 Supplement 3 p. S37-S40
4 p.
article
129 1.083 VALIDATION OF THE MONTREAL COGNITIVE ASSESSMENT (MOCA) IN DETECTING COGNITIVE IMPAIRMENT IN SINGAPOREAN PARKINSON DISEASE PATIENTS — PILOT DATA Lim, E.C.H.
2012
18 Supplement 3 p. S30-
1 p.
article
130 3.044 VARIANT IN THE 3' REGION OF SNCA ASSOCIATED WITH PARKINSON'S DISEASE AND SERUM α-SYNUCLEIN LEVELS Hu, Y.
2012
18 Supplement 3 p. S179-S180
2 p.
article
131 1.10.1 WHAT ABOUT BRAAK Alafuzoff, I.
2012
18 Supplement 3 p. S5-
1 p.
article
132 What are the issues facing Parkinson's disease patients at ten years of disease and beyond?: Data from the NPF-QII study Hassan, Anhar
2012
18 Supplement 3 p. S10-S14
5 p.
article
                             132 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands